Efgartigimod Alfa

ATC L04AL01 · 8 markets · 18 records

Efgartigimod Alfa 8 markets · 18 records Forms

AU 4 records · 4 strengths

  • 20 mg/mLinjectionVYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial also in SG unknown
  • 200 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5 mL solution for injection prefilled syringe unknown
  • 180 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 3 records · 3 strengths

GB 2 records · 2 strengths

  • 1,000 mg/5.6 mLinjectionVyvgart 1000mg/5.6ml solution for injection vials
  • 400 mg/20 mLinjectionVyvgart 400mg/20ml concentrate for solution for infusion vials

CA 2 records · 2 strengths

  • 200 mgliquidVYVGART SC
  • 20 mgliquidVYVGART

ES 2 records · 2 strengths

FR 2 records · 2 strengths

  • 1,000 mginjectionVYVGART 1000 mg, solution injectable also in ES
  • 400 mginjectionVYVGART 20 mg/mL, solution à diluer pour perfusion

SG 1 records · 1 strengths

  • 20 mg/mLinjectionVYVGART CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ML also in AU

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.